HAMPTON, N.J. (AP) — HAMPTON, N.J. (AP) — Celldex Therapeutics Inc. (CLDX) on Monday reported a loss of $43.3 million in its fourth quarter.
On a per-share basis, the Hampton, New Jersey-based company said it had a loss of 83 cents. Losses, adjusted for non-recurring costs, were 57 cents per share.
The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 76 cents per share.
The biopharmaceutical company posted revenue of $4.1 million in the period.
For the year, the company reported a loss of $141.4 million, or $2.92 per share. Revenue was reported as $6.9 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CLDX at https://www.zacks.com/ap/CLDX